Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen.
暂无分享,去创建一个
B. Katzenellenbogen | B. van der Burg | P. T. van der Saag | S. Wissink | Bart Van Der Burg | B. van der Burg | Bart van der Burg
[1] H. Pols,et al. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. , 1999, Biochemical and biophysical research communications.
[2] B. McEwen,et al. Estrogen actions in the central nervous system. , 1999, Endocrine reviews.
[3] V. Giguère,et al. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.
[4] A D Vethaak,et al. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[5] L. Cohen,et al. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? , 1998, Biological Psychiatry.
[6] G. Fink,et al. SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY , 1998, Clinical and experimental pharmacology & physiology.
[7] N. Weigel,et al. Ligand-independent activation of steroid hormone receptors , 1998, Journal of Molecular Medicine.
[8] P. Shughrue,et al. Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.
[9] L. Koenderman,et al. NF-κB/Rel Family Members Regulating the ICAM-1 Promoter in Monocytic THP-1 Cells , 1997 .
[10] E. Kalkhoven,et al. Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid Receptor* , 1997, The Journal of Biological Chemistry.
[11] C. Kaltschmidt,et al. NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.
[12] M. Buhot. Serotonin receptors in cognitive behaviors , 1997, Current Opinion in Neurobiology.
[13] B. Spiegelman,et al. Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.
[14] A. Israël,et al. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.
[15] T. García,et al. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. , 1996, Molecular endocrinology.
[16] M. Elgort,et al. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence. , 1996, Molecular endocrinology.
[17] J. Studd,et al. Transdermal oestrogen for treatment of severe postnatal depression , 1996, The Lancet.
[18] Daniel Metzger,et al. Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.
[19] B Stein,et al. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.
[20] G. McNeil,et al. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins. , 1995, Molecular endocrinology.
[21] P. Webb,et al. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.
[22] J. Gustafsson,et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.
[23] S. Safe,et al. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. , 1994, The Journal of biological chemistry.
[24] A. Ray,et al. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. , 1994, The Journal of biological chemistry.
[25] B. Katzenellenbogen,et al. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.
[26] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[27] M. Pompeiano,et al. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] S. Watson,et al. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study , 1991, Brain Research.
[29] K. Korach,et al. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. , 1991, Endocrinology.
[30] D. Murphy,et al. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[31] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[32] U. Halbreich. Psychiatric disorders associated with specific periods in women's lives. , 1990, The American journal of psychiatry.
[33] H. V. Van Tol,et al. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.
[34] N. Webster,et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.
[35] M. Caron,et al. Effector coupling mechanisms of the cloned 5-HT1A receptor. , 1989, The Journal of biological chemistry.
[36] M. Blankenstein,et al. Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen , 1988, Journal of cellular physiology.
[37] P. Argos,et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.
[38] J. Shine,et al. Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.
[39] G. Oppenheim. Estrogen in the treatment of depression: neuropharmacological mechanisms. , 1983, Biological psychiatry.
[40] B. McEwen,et al. Modulation by estradiol of serotonin receptors in brain , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] B. Katzenellenbogen,et al. Transcription Activation by the Human Estrogen Receptor Subtype b ( ER b ) Studied with ER b and ER a Receptor Chimeras * , 1998 .
[42] G. Fink,et al. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. , 1997, Brain research. Molecular brain research.
[43] J. Gustafsson,et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.
[44] J. Polman,et al. ER beta: identification and characterization of a novel human estrogen receptor. , 1996, FEBS letters.
[45] Maria X. Yang. Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF- (cid:107) B and C/EBP (cid:98) , 1995 .
[46] M. Tzukerman,et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. , 1994, Molecular endocrinology.
[47] D. Julius. Molecular biology of serotonin receptors. , 1991, Annual review of neuroscience.
[48] J. Lehmann,et al. Nuclear retinoic acid receptors: cloning, analysis, and function. , 1990, Methods in enzymology.
[49] K. Lesch,et al. [The serotonin hypothesis of depression]. , 1990, Fortschritte der Neurologie-Psychiatrie.
[50] J. Gustafsson,et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .